Legend Biotech to Participate in the Morgan Stanley Global Healthcare Conference

Rhea-AI Summary

Legend Biotech (NASDAQ: LEGN), a global cell therapy leader, has announced its participation in the upcoming Morgan Stanley Global Healthcare Conference. The company's CEO, Dr. Ying Huang, will engage in a fireside chat on September 9, 2025, at 4:05 p.m. ET in New York.

Investors can access the live webcast through Legend Biotech's Investor Relations website section, with a replay becoming available approximately 48 hours after the event.

SOMERSET, N.J., Aug. 26, 2025 (GLOBE NEWSWIRE) -- Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global leader in cell therapy, today announced that Ying Huang, Ph.D., the company’s Chief Executive Officer, will participate in a fireside chat at the Morgan Stanley Global Healthcare Conference in New York, NY on Tuesday, September 9, 2025, at 4:05 p.m. ET.

The live webcast will be available to investors and other interested parties by accessing the Investor Relations section of Legend’s website. The webcast replay will be available approximately 48 hours after the webcast.

ABOUT LEGEND BIOTECH 

With over 2,800 employees, Legend Biotech is the largest standalone cell therapy company and a pioneer in treatments that change cancer care forever. The company is at the forefront of the CAR-T cell therapy revolution with CARVYKTI^®, a one-time treatment for relapsed or refractory multiple myeloma, which it develops and markets with collaborator Johnson & Johnson. Headquartered in the US, Legend is building an end-to-end cell therapy company by expanding its leadership to maximize CARVYKTI’s patient access and therapeutic potential. From this platform, the company plans to drive future innovation across its pipeline of cutting-edge cell therapy modalities.

Learn more at www.legendbiotech.com and follow us on X (formerly Twitter) and LinkedIn.

INVESTOR CONTACT: 
Jessie Yeung 
Tel: (732) 956-8271  
jessie.yeung@legendbiotech.com 

PRESS CONTACT: 
Mary Ann Ondish 
Tel: (914) 552-4625 
media@legendbiotech.com 

FAQ

When is Legend Biotech (LEGN) presenting at the Morgan Stanley Healthcare Conference 2025?

Legend Biotech's CEO will present on Tuesday, September 9, 2025, at 4:05 p.m. ET in New York, NY.

Who will represent Legend Biotech at the Morgan Stanley Conference 2025?

Dr. Ying Huang, Legend Biotech's Chief Executive Officer, will participate in a fireside chat at the conference.

How can investors watch Legend Biotech's Morgan Stanley Conference presentation?

Investors can watch the live webcast through the Investor Relations section of Legend Biotech's website. A replay will be available approximately 48 hours after the presentation.

What type of presentation will Legend Biotech (LEGN) give at the Morgan Stanley Conference?

Legend Biotech's CEO will participate in a fireside chat format presentation at the conference.